Halozyme Therapeutics Inc. （HALO.US） What is the potential upside on pending launches， new partnerships？

12 August 2024 | 2:31AM EDT 2131d4eaf4cb4d50b1d51c8af07b64b4 Halozyme Therapeutics Inc. (HALO): What is the potential upside on pending launches, new partnerships? HALO's revenue and cash flows are primarily (and increasingly) driven by royalty revenues on Enhanze partnered products, which offer predictable and high margin growth, consistent with management guidance through 2028. However, we frequently field questions on where there is potential discovery value on this platform, thus we highlight two avenue ...